Clinical trial
Treatment With Namenda in Women at Risk for Cognitive Decline
NCT00242632 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00242632 |
|---|---|
| Title | Treatment With Namenda in Women at Risk for Cognitive Decline |
| Official title | Cognitive Effects of Memantine in Postmenopausal Women at Risk of Dementia: a Pilot Study |
| Lead sponsor | Stanford University, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Dementia |
| Intervention type | Drug |
| Interventions | Namenda |
| Enrollment | 22 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Oct 20, 2005 |
| Last update posted | Jun 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: